CHU Bordeaux, Bordeaux, France.
Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands.
Clin Nutr. 2018 Dec;37(6 Pt A):2084-2090. doi: 10.1016/j.clnu.2017.09.027. Epub 2017 Oct 6.
BACKGROUND & AIMS: Several studies with diabetes-specific formulas (DSFs) for hyperglycaemic patients in need of nutritional support have been conducted in non-malnourished patients, mainly comparing products with varying macronutrient compositions. Here, the effect of a high energy, high protein DSF on postprandial responses was compared to a product with a similar macronutrient composition in malnourished or at risk of malnutrition patients with type 2 diabetes.
In this randomised, double-blind cross-over study, 20 patients were included. After overnight fasting, patients consumed 200 mL of a DSF or standard supplement (control) (19.6 g protein, 31.2 g carbohydrates and 10.6 g fat), while continuing their anti-diabetic medication. The formulas differed in type of carbohydrates and presence of fibre. The postprandial glucose, insulin and glucagon responses were monitored over 4 h. Data were analysed with a Linear Mixed Model, and results of the modified ITT population (n = 19) are shown.
Postprandial glucose response as incremental area under the curve (iAUC), was lower after consumption of DSF compared with control (489.7 ± 268.5 (mean ± SD) vs 581.3 ± 273.9 mmol/L min, respectively; p = 0.008). Also, the incremental maximum concentration of glucose (iCmax) was lower for DSF vs control (3.5 ± 1.4 vs 4.0 ± 1.4 mmol/L; p = 0.007). Postprandial insulin and glucagon levels, expressed as iAUC or iCmax, were not significantly different between groups.
Consumption of a high energy, high protein DSF by older malnourished or at risk of malnutrition type 2 diabetes patients resulted in a significantly lower glucose response compared to control. These data suggest that the use of a DSF is preferred for patients with diabetes in need of nutritional support.
已有多项针对需要营养支持的高血糖患者的糖尿病专用配方(DSF)研究在非营养不良患者中进行,主要比较了不同宏量营养素组成的产品。在此,我们比较了一种高能量、高蛋白 DSF 与一种宏量营养素组成相似的产品在患有 2 型糖尿病的营养不良或有营养不良风险的患者中的餐后反应。
这是一项随机、双盲交叉研究,共纳入 20 例患者。患者禁食过夜后,分别饮用 200ml 的 DSF 或标准补充剂(对照)(含 19.6g 蛋白质、31.2g 碳水化合物和 10.6g 脂肪),同时继续服用抗糖尿病药物。两种配方的碳水化合物类型和膳食纤维含量不同。4 小时内监测餐后血糖、胰岛素和胰高血糖素反应。采用线性混合模型进行数据分析,结果以改良意向治疗人群(n=19)表示。
与对照相比,DSF 组餐后血糖反应的增量曲线下面积(iAUC)更低(分别为 489.7±268.5 和 581.3±273.9mmol/L·min;p=0.008)。此外,DSF 组的血糖增量最大浓度(iCmax)也低于对照(分别为 3.5±1.4 和 4.0±1.4mmol/L;p=0.007)。两组餐后胰岛素和胰高血糖素水平的 iAUC 或 iCmax 均无显著差异。
对于年老的营养不良或有营养不良风险的 2 型糖尿病患者,摄入高能量、高蛋白 DSF 可显著降低餐后血糖反应。这些数据表明,对于需要营养支持的糖尿病患者,使用 DSF 更为理想。